Skip to main content
Clinical Trials/NCT06602830
NCT06602830CompletedNot Applicable

I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery -a Prospective Observational Study-

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country48 target enrollmentStarted: October 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
Leak fraction

Study Overview

Brief Summary

i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. During laparoscopic surgery intrabdominal pressure is increased by capnoperitoneum and frequently minute ventilation has to be adopted to counteract hypercapnia, and higher inspiratory peak pressures have to be expected. It is uncertain, however, if the i-gel Plus facilitates appropriate ventilation with low leakage volumes in patients undergoing laparoscopic surgery.

The primary aim of this single-center non-inferiority study is to assess the leak fraction of the i-gel Plus under conditions of capnoperitoneum (with and without Trendelenburg position) and to compare it with baseline conditions. Secondary aims are to assess secondary outcome parameters during capnoperitoneum (with and without Trendelenburg position) and to compare them with baseline conditions.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients scheduling for elective laparoscopic surgery
  • Planned airway management using a SGA
  • Adult patients (age 18-89 years)
  • ASA physical status 1-3

Exclusion Criteria

  • Pregnant or breastfeeding women
  • Non-fasted patients
  • Increased risk of aspiration or other contraindications for supraglottic mask ventilation
  • Body mass index (BMI) >35 kg/m2
  • Inability to understand or sign informed consent

Outcomes

Primary Outcomes

Leak fraction

Time Frame: 3 houres

Ventilation parameter - volume per tidal volume

Secondary Outcomes

  • Oropharyngeal seal pressure [cm H2O](3 houres)
  • Leakage volume (ml)(3 houres)
  • Tidal volume (ml)(3 houres)
  • Inspiratory peak pressure (cm H2O)(3 houres)
  • Positive endexpiratory pressure (PEEP) (cm H2O)(3 houres)
  • Intraabdominal pressure under capnoperitoneum [mmHg](3 houres)
  • Postoperative complications(24 hours postoperatively)
  • Respiratory rate (1/min)(3 houres)
  • Minute ventilation (l/min/kg)(3 houres)
  • Endtidal CO2 [mmHg](3 houres)
  • Number of insertion attempts(3 houres)
  • Insertion success rate (%)(3 houres)
  • First-attempt insertion success rate (%)(3 houres)
  • Necessity of adjustment maneuvers during the procedure(3 houres)
  • Insertion time (sec)(3 houres)
  • Difficulty of insertion(3 houres)
  • Ease of gastric tube insertion(3 houres)
  • Lowest oxygen saturation (%)(3 houres)
  • Complications at the end of surgery(3 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials